Myeloma Investment Fund
North America, Massachusetts, United States, Brookline
Description
Myeloma Investment Fund is a new, independent, self-sustaining venture fund.
Investor Profile
Myeloma Investment Fund has made 11 investments, with 6 in the past 12 months and 36% as lead.
Stage Focus
- Series A (27%)
- Seed (27%)
- Series Unknown (27%)
- Series B (9%)
- Series C (9%)
Country Focus
- United States (73%)
- Canada (18%)
- Israel (9%)
Industry Focus
- Biotechnology
- Medical
- Health Care
- Therapeutics
- Biopharma
- Clinical Trials
- Service Industry
- Oncology
- Pharmaceutical
- Developer Platform
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
